What is Scientific Ind's earnings per share (EPS)?

Scientific Ind (SCND) reported diluted earnings per share of $-0.11 for fiscal year 2025. This represents a 82.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Scientific Ind Financials

SCND

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE March

This page shows Scientific Ind (SCND) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 33/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Scientific Ind has an operating margin of -156.1%, meaning the company retains $-156 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -62.0% the prior year.

Growth

Scientific Ind's revenue declined 52.8% year-over-year, from $10.7M to $5.1M. This contraction results in a growth score of 0/100.

Leverage

Scientific Ind carries a low D/E ratio of 0.18, meaning only $0.18 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 7.70, Scientific Ind holds $7.70 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

While Scientific Ind generated -$8.1M in operating cash flow, capex of $63K consumed most of it, leaving -$8.2M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Scientific Ind generates a -11.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -70.7% the prior year.

Piotroski F-Score Weak

3/9

Scientific Ind passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Low Quality

6.68x

For every $1 of reported earnings, Scientific Ind generates $6.68 in operating cash flow (-$8.1M OCF vs -$1.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$5.1M

YoY-52.8%

5Y CAGR-13.1%

10Y CAGR-2.9%

Scientific Ind generated $5.1M in revenue in fiscal year 2025. This represents a decrease of 52.8% from the prior year.

EBITDA

-$7.3M

YoY-23.7%

Scientific Ind's EBITDA was -$7.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 23.7% from the prior year.

Net Income

-$1.2M

YoY+81.1%

Scientific Ind reported -$1.2M in net income in fiscal year 2025. This represents an increase of 81.1% from the prior year.

EPS (Diluted)

$-0.11

YoY+82.0%

Scientific Ind earned $-0.11 per diluted share (EPS) in fiscal year 2025. This represents an increase of 82.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$8.2M

YoY-117.1%

Scientific Ind generated -$8.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 117.1% from the prior year.

Cash & Debt

$955K

YoY+62.4%

5Y CAGR-9.8%

10Y CAGR+6.8%

Scientific Ind held $955K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

12M

YoY+0.0%

5Y CAGR+51.5%

10Y CAGR+23.1%

Scientific Ind had 12M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

25.8%

YoY-18.4pp

5Y CAGR-17.0pp

10Y CAGR-12.7pp

Scientific Ind's gross margin was 25.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 18.4 percentage points from the prior year.

Operating Margin

-156.1%

YoY-94.1pp

5Y CAGR-163.7pp

10Y CAGR-154.4pp

Scientific Ind's operating margin was -156.1% in fiscal year 2025, reflecting core business profitability. This is down 94.1 percentage points from the prior year.

Net Margin

-24.1%

YoY+36.0pp

5Y CAGR-30.5pp

10Y CAGR-23.0pp

Scientific Ind's net profit margin was -24.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 36.0 percentage points from the prior year.

Return on Equity

-11.5%

YoY+59.2pp

5Y CAGR-21.6pp

10Y CAGR-10.1pp

Scientific Ind's ROE was -11.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 59.2 percentage points from the prior year.

Capital Allocation

R&D Spending

$2.5M

YoY-14.4%

5Y CAGR+36.2%

10Y CAGR+19.3%

Scientific Ind invested $2.5M in research and development in fiscal year 2025. This represents a decrease of 14.4% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$63K

YoY-36.1%

5Y CAGR-19.6%

10Y CAGR+2.4%

Scientific Ind invested $63K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 36.1% from the prior year.

SCND Income Statement

Metric	FY25	FY24	FY23	FY22	FY20	FY19
Revenue	$5.1M-52.8%	$10.7M-3.6%	$11.1M-2.5%	$11.4M+46.5%	$7.8M-23.7%	$10.2M
Cost of Revenue	$3.8M-37.3%	$6.0M-0.5%	$6.0M+6.1%	$5.7M+47.2%	$3.8M-34.0%	$5.8M
Gross Profit	$1.3M-72.5%	$4.7M-7.2%	$5.1M-11.1%	$5.7M+45.7%	$3.9M-9.8%	$4.4M
R&D Expenses	$2.5M-14.4%	$2.9M-18.5%	$3.6M+24.1%	$2.9M+152.1%	$1.1M+114.8%	$531K
SG&A Expenses	$3.3M-32.2%	$4.8M-11.0%	$5.4M-6.9%	$5.8M+155.6%	$2.3M+18.2%	$1.9M
Operating Income	-$7.9M-18.9%	-$6.6M+28.3%	-$9.3M+19.8%	-$11.5M-1639.9%	-$664K-185.5%	$776K
Interest Expense	N/A	N/A	N/A	N/A	$0-100.0%	$2K
Income Tax	$5K	$0	$0-100.0%	$2.4M+648.5%	-$437K-450.4%	$125K
Net Income	-$1.2M+81.1%	-$6.4M+29.1%	-$9.1M+33.5%	-$13.7M-1843.4%	-$703K-208.9%	$646K
EPS (Diluted)	$-0.11+82.0%	$-0.61+52.0%	$-1.27	N/A	$-0.46-207.0%	$0.43

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$1.4M-39.7%	$2.3M-3.2%	$2.4M-43.3%	$4.2M+218.3%	$1.3M-49.6%	$2.6M+6.6%	$2.5M-9.3%	$2.7M
Cost of Revenue	$765K-41.6%	$1.3M-5.7%	$1.4M-45.0%	$2.5M+286.1%	$655K-51.7%	$1.4M-6.1%	$1.4M-4.1%	$1.5M
Gross Profit	$639K-37.4%	$1.0M+0.3%	$1.0M-40.9%	$1.7M+153.1%	$680K-47.4%	$1.3M+24.2%	$1.0M-15.6%	$1.2M
R&D Expenses	$621K-8.2%	$677K+3.9%	$652K-26.4%	$885K+37.5%	$644K-3.3%	$666K-6.3%	$711K-40.5%	$1.2M
SG&A Expenses	$804K-17.6%	$976K-22.0%	$1.3M-14.2%	$1.5M+86.7%	$781K-26.5%	$1.1M-30.2%	$1.5M-7.9%	$1.7M
Operating Income	-$1.5M+1.5%	-$1.5M+14.7%	-$1.8M-10.0%	-$1.6M-5.2%	-$1.6M-17.2%	-$1.3M+36.1%	-$2.1M+10.7%	-$2.3M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	$0	$0	$0	$0	$0+100.0%	-$109K
Net Income	$4.0M+362.3%	-$1.5M+14.4%	-$1.8M+7.9%	-$1.9M-63.6%	-$1.2M+8.1%	-$1.3M+37.4%	-$2.1M+7.7%	-$2.2M
EPS (Diluted)	$0.34+361.5%	$-0.13-181.3%	$0.16	N/A	$-0.11+8.3%	$-0.12-160.0%	$0.20	N/A

SCND Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY20	FY19
Total Assets	$12.6M+9.1%	$11.6M-30.9%	$16.7M-20.4%	$21.0M+42.0%	$14.8M+78.8%	$8.3M
Current Assets	$10.4M+25.4%	$8.3M-32.8%	$12.3M-24.1%	$16.3M+27.7%	$12.7M+93.2%	$6.6M
Cash & Equivalents	$955K+62.4%	$588K-26.2%	$796K-73.2%	$3.0M-60.7%	$7.6M+371.7%	$1.6M
Inventory	$1.4M-31.9%	$2.1M-57.8%	$4.9M+4.0%	$4.7M+84.8%	$2.5M-2.0%	$2.6M
Accounts Receivable	$866K+47.0%	$589K-49.1%	$1.2M-22.9%	$1.5M+41.1%	$1.1M-46.1%	$2.0M
Goodwill	$115K0.0%	$115K0.0%	$115K0.0%	$115K-55.2%	$257K-63.5%	$705K
Total Liabilities	$1.9M-20.3%	$2.4M-14.2%	$2.8M-18.0%	$3.5M+12.8%	$3.1M+58.9%	$1.9M
Current Liabilities	$1.3M-22.8%	$1.7M-4.9%	$1.8M-17.6%	$2.2M+1.9%	$2.2M+38.0%	$1.6M
Long-Term Debt	N/A	N/A	N/A	N/A	$0	N/A
Total Equity	$10.7M+16.9%	$9.1M-34.3%	$13.9M-20.8%	$17.5M+49.6%	$11.7M+84.9%	$6.3M
Retained Earnings	-$35.2M-203.6%	$33.9M+223.5%	-$27.5M-91.9%	-$14.3M-573.9%	$3.0M-18.9%	$3.7M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$14.6M+42.4%	$10.2M-3.3%	$10.6M-8.6%	$11.6M-13.1%	$13.3M-6.8%	$14.3M-8.2%	$15.5M-7.1%	$16.7M
Current Assets	$11.9M+64.9%	$7.2M-2.5%	$7.4M-10.8%	$8.3M-14.1%	$9.7M-7.1%	$10.4M-8.9%	$11.4M-7.6%	$12.3M
Cash & Equivalents	$1.2M+30.4%	$891K+89.6%	$470K-20.0%	$588K+4.3%	$564K+0.5%	$561K+59.4%	$352K-55.8%	$796K
Inventory	$2.0M-53.5%	$4.4M+0.9%	$4.4M+111.4%	$2.1M-61.8%	$5.4M-0.2%	$5.4M+10.8%	$4.9M-0.3%	$4.9M
Accounts Receivable	$678K-29.9%	$966K-20.0%	$1.2M+104.9%	$589K-56.6%	$1.4M+11.7%	$1.2M+6.1%	$1.1M-1.1%	$1.2M
Goodwill	$115K0.0%	$115K0.0%	$115K0.0%	$115K0.0%	$115K0.0%	$115K0.0%	$115K0.0%	$115K
Total Liabilities	$2.1M-6.1%	$2.2M-20.4%	$2.8M+14.8%	$2.4M+2.9%	$2.4M-8.5%	$2.6M-11.4%	$2.9M+2.9%	$2.8M
Current Liabilities	$1.6M-8.4%	$1.7M-20.5%	$2.1M+22.1%	$1.7M+8.5%	$1.6M-9.2%	$1.8M-13.5%	$2.1M+11.6%	$1.8M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$12.5M+57.3%	$7.9M+2.0%	$7.8M-14.8%	$9.1M-16.6%	$10.9M-6.4%	$11.7M-7.4%	$12.6M-9.1%	$13.9M
Retained Earnings	-$33.2M+10.7%	-$37.2M-4.3%	-$35.7M-205.2%	$33.9M+206.0%	-$32.0M-3.8%	-$30.8M-4.3%	-$29.5M-7.5%	-$27.5M

SCND Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY20	FY19
Operating Cash Flow	-$8.1M-121.2%	-$3.7M+40.2%	-$6.2M-18.6%	-$5.2M-2987.6%	-$168K-114.5%	$1.2M
Capital Expenditures	$63K-36.1%	$99K-24.9%	$132K-82.6%	$758K+1388.4%	$51K-72.9%	$188K
Free Cash Flow	-$8.2M-117.1%	-$3.8M+39.8%	-$6.3M-5.7%	-$5.9M-2615.9%	-$219K-122.5%	$972K
Investing Cash Flow	$3.8M+33.7%	$2.9M+489.9%	-$735K+80.4%	-$3.7M-4358.1%	-$84K+61.5%	-$218K
Financing Cash Flow	$2.0M+202.3%	$646K-88.8%	$5.8M+149.3%	$2.3M-62.9%	$6.2M+1685.2%	-$392K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$1.6M-13.7%	-$1.4M-7.6%	-$1.3M-364.9%	$503K+128.7%	-$1.7M-100.7%	-$872K+44.3%	-$1.6M-17.4%	-$1.3M
Capital Expenditures	$10K+50.7%	$7K-73.8%	$26K+14.8%	$23K+502.6%	$4K-84.6%	$25K-48.0%	$48K+244.2%	$14K
Free Cash Flow	-$1.6M-13.9%	-$1.4M-6.0%	-$1.4M-383.0%	$480K+127.4%	-$1.8M-95.6%	-$896K+44.4%	-$1.6M-19.7%	-$1.3M
Investing Cash Flow	$864K+129.3%	$377K-68.7%	$1.2M+176.1%	$436K-49.2%	$859K-21.2%	$1.1M+126.8%	$481K+111.6%	-$4.1M
Financing Cash Flow	$500K-65.6%	$1.5M	$0	$0	$0	$0-100.0%	$646K-88.7%	$5.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

SCND Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY20	FY19
Gross Margin	25.8%-18.4pp	44.2%-1.7pp	45.9%-4.4pp	50.3%-0.3pp	50.6%+7.8pp	42.8%
Operating Margin	-156.1%-94.1pp	-62.0%+21.4pp	-83.3%+17.9pp	-101.3%-92.7pp	-8.5%-16.1pp	7.6%
Net Margin	-24.1%+36.0pp	-60.2%+21.6pp	-81.8%+38.1pp	-119.9%-110.9pp	-9.0%-15.4pp	6.3%
Return on Equity	-11.5%+59.2pp	-70.7%-5.2pp	-65.4%+12.5pp	-77.9%-71.9pp	-6.0%-16.2pp	10.2%
Return on Assets	-9.7%+46.1pp	-55.8%-1.4pp	-54.3%+10.7pp	-65.1%-60.3pp	-4.8%-12.6pp	7.8%
Current Ratio	7.70+3.0	4.74-2.0	6.72-0.6	7.29+1.5	5.82+1.7	4.16
Debt-to-Equity	0.18-0.1	0.27+0.1	0.200.0	0.20+0.2	0.00-0.3	0.31
FCF Margin	-162.5%-127.2pp	-35.3%+21.3pp	-56.6%-4.4pp	-52.2%-49.4pp	-2.8%-12.3pp	9.5%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	45.5%+1.7pp	43.8%+1.5pp	42.2%+1.7pp	40.5%-10.4pp	50.9%+2.1pp	48.8%+6.9pp	41.9%-3.1pp	45.0%
Operating Margin	-108.4%-42.1pp	-66.3%+8.9pp	-75.3%-36.5pp	-38.8%+78.6pp	-117.3%-66.9pp	-50.5%+33.7pp	-84.1%+1.3pp	-85.5%
Net Margin	284.5%+349.9pp	-65.3%+8.6pp	-73.9%-28.5pp	-45.4%+43.0pp	-88.4%-39.9pp	-48.5%+34.1pp	-82.6%-1.4pp	-81.2%
Return on Equity	32.0%+51.3pp	-19.2%+3.7pp	-22.9%-1.7pp	-21.2%-10.4pp	-10.8%+0.2pp	-11.0%+5.3pp	-16.3%-0.3pp	-16.0%
Return on Assets	27.4%+42.3pp	-14.9%+1.9pp	-16.8%-0.1pp	-16.7%-7.8pp	-8.9%+0.1pp	-9.0%+4.2pp	-13.2%+0.1pp	-13.3%
Current Ratio	7.65+3.4	4.25+0.8	3.47-1.3	4.74-1.2	5.99+0.1	5.85+0.3	5.56-1.2	6.72
Debt-to-Equity	0.17-0.1	0.28-0.1	0.36+0.1	0.27+0.1	0.220.0	0.22-0.0	0.23+0.0	0.20
FCF Margin	-116.7%-54.9pp	-61.8%-5.3pp	-56.4%-67.7pp	11.3%+142.7pp	-131.4%-97.5pp	-33.9%+31.1pp	-64.9%-15.7pp	-49.2%

Similar Companies

Lifeloc Technologies Inc LCTC

$5.1M

Global Warm GWSO

$11.5M

Nanalysis Sci NSCIF

$11.5M

Eddy Smart Home ESHSF

$6.1M

Darkpulse DPLS

$910K

Frequently Asked Questions

What is Scientific Ind's annual revenue?

Scientific Ind (SCND) reported $5.1M in total revenue for fiscal year 2025. This represents a -52.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Scientific Ind's revenue growing?

Scientific Ind (SCND) revenue declined by 52.8% year-over-year, from $10.7M to $5.1M in fiscal year 2025.

Is Scientific Ind profitable?

No, Scientific Ind (SCND) reported a net income of -$1.2M in fiscal year 2025, with a net profit margin of -24.1%.

What is Scientific Ind's EBITDA?

Scientific Ind (SCND) had EBITDA of -$7.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Scientific Ind's gross margin?

Scientific Ind (SCND) had a gross margin of 25.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Scientific Ind's operating margin?

Scientific Ind (SCND) had an operating margin of -156.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Scientific Ind's net profit margin?

Scientific Ind (SCND) had a net profit margin of -24.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Scientific Ind's return on equity (ROE)?

Scientific Ind (SCND) has a return on equity of -11.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Scientific Ind's free cash flow?

Scientific Ind (SCND) generated -$8.2M in free cash flow during fiscal year 2025. This represents a -117.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Scientific Ind's operating cash flow?

Scientific Ind (SCND) generated -$8.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Scientific Ind's total assets?

Scientific Ind (SCND) had $12.6M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Scientific Ind's capital expenditures?

Scientific Ind (SCND) invested $63K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Scientific Ind spend on research and development?

Scientific Ind (SCND) invested $2.5M in research and development during fiscal year 2025.

How many shares does Scientific Ind have outstanding?

Scientific Ind (SCND) had 12M shares outstanding as of fiscal year 2025.

What is Scientific Ind's current ratio?

Scientific Ind (SCND) had a current ratio of 7.70 as of fiscal year 2025, which is generally considered healthy.

What is Scientific Ind's debt-to-equity ratio?

Scientific Ind (SCND) had a debt-to-equity ratio of 0.18 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Scientific Ind's return on assets (ROA)?

Scientific Ind (SCND) had a return on assets of -9.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Scientific Ind's cash runway?

Based on fiscal year 2025 data, Scientific Ind (SCND) had $955K in cash against an annual operating cash burn of $8.1M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Scientific Ind's Piotroski F-Score?

Scientific Ind (SCND) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Scientific Ind's earnings high quality?

Scientific Ind (SCND) has an earnings quality ratio of 6.68x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Scientific Ind?

Scientific Ind (SCND) scores 33 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.